Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cora Health vs TeleFirst Med

Cora Health
Graded #81

Higher grade

vs+14.800000000000004
TeleFirst Med
Graded #400

Lower grade

The verdict

Cora Health takes it — 72.2/100 to 57.4/100.

Cora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCora Health +28
73
45
Dose & formulationCora Health +19
72
53
Clinical oversightEven
82
82
Labs & monitoringCora Health +2
54
52
FulfillmentCora Health +31
89
58
Contract termsEven
55
55
Cora Health · left barTeleFirst Med · right bar

The numbers

MetricCora HealthTeleFirst Med
WeighScore72.2/10057.4/100
GradeCC
Scorecard rank#81#400
Semaglutide$175/moNot disclosed
Tirzepatide$225/moNot disclosed
CoverageAll 50 states2 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Cora Health

Graded #81 · C

Strengths

  • Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
  • Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
  • LegitScript Certified (seal ID 49690100 in footer)
  • Flat per-tier pricing — no dose-escalation surcharge
  • Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide

Where it loses points

  • Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
  • Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
  • Lowest advertised prices require 12-month commitment with no partial refunds
  • No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
  • Founder names and funding undisclosed on site
TeleFirst Med

Graded #400 · C

Strengths

  • Prescribes real brand-name GLP-1 (e.g. Ozempic/Wegovy), not compounded — appealing if you specifically want FDA-approved branded medication
  • Simple $120 telehealth evaluation with a licensed doctor; no insurance hassle and no prior authorization
  • You fill the prescription at your own regular pharmacy rather than waiting on a mail-order compounding pharmacy
  • Also a general telehealth clinic (urgent care, chronic-condition management) if you want broader care

Where it loses points

  • Only Texas and North Carolina are confirmed — not available nationwide
  • The $120 is an evaluation fee; the brand-name medication is billed separately at your pharmacy and can be expensive without insurance
  • Small practice (about 500 patients) with limited public detail on its clinicians and program
  • No compounded or lower-cost medication option, and no medication pricing is published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard